Literature DB >> 8112389

Riluzole prevents anoxic injury in cultured cerebellar granule neurons.

F Dessi1, Y Ben-Ari, C Charriaut-Marlangue.   

Abstract

Glutamate release has been reported to be involved in the neuronal death following ischemic or anoxic injury. Riluzole (2-amino-6-trifluoromethoxy-benzothiazole) is a putative inhibitor of glutamate release. We investigated the effect of this drug on anoxic injury in vitro. Cerebellar granule cells grown in culture were exposed to an anoxic atmosphere for 16-20 h, Riluzole (100 microM) was found to prevent the degeneration of these neurons induced by anoxia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112389     DOI: 10.1016/0014-2999(93)90398-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury.

Authors:  Xiao-Ya Gao; Jian-Ou Huang; Ya-Fang Hu; Yong Gu; Shu-Zhen Zhu; Kai-Bin Huang; Jin-Yu Chen; Su-Yue Pan
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

2.  Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.

Authors:  Claudia Albertini; Alessandra Salerno; Silvia Atzeni; Elisa Uliassi; Francesca Massenzio; Annalisa Maruca; Roberta Rocca; Marko Mecava; Filomena S G Silva; Débora Mena; Pedro Valente; Ana I Duarte; Daniel Chavarria; Maicol Bissaro; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Ondřej Soukup; Fernanda Borges; Stefano Alcaro; Barbara Monti; Paulo J Oliveira; Josè C Menéndez; Maria Laura Bolognesi
Journal:  ACS Chem Neurosci       Date:  2022-07-22       Impact factor: 5.780

3.  Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.

Authors:  Rodolphe Hajj; Aude Milet; Damien Toulorge; Nathalie Cholet; Julien Laffaire; Julie Foucquier; Sandra Robelet; Richard Mitry; Mickael Guedj; Serguei Nabirotchkin; Ilya Chumakov; Daniel Cohen
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.